The novel coronavirus disease (COVID-19) pandemic has created a shift in the conduct of healthcare, particularly in the use of digital technology in enabling virtual experiences for both physicians and patients, as suggested by experts in the recently concluded 2020 Virtual Forum of the Asia Pacific Medical Technology Association (APACMed 2020).
From a typical brick-and-mortar environment to the application of digital and data technologies to engage patients at a safe distance, the pandemic has facilitated a shift in the delivery of healthcare.
The coronavirus disease (COVID-19) pandemic appears to have quickened the acceptance of prescription digital therapeutics (PDT), or software that helps treat human disease, by clinicians and patients, particularly those suffering from mental health conditions, according to experts from one of the sessions at the 2020 Virtual Forum of the Asia Pacific Medical Technology Association (APACMed 2020).
Digital technology is key in improving access to healthcare. This was the key message in one of the breakout sessions during the recently concluded 2020 Virtual Forum of the Asia Pacific Medical Technology Association (APACMed 2020). Especially under lockdowns due to the coronavirus pandemic, digital health allows providers to continuously deliver services to their patients.
Asia's trusted medical magazine for healthcare professionals.
Get your MIMS Doctor - Malaysia digital copy today!
Not only does the CGRP* inhibitor galcanezumab show sustained efficacy in migraine patients, long-term treatment does not come with excess cardiovascular (CV) risk, according to studies presented at the AAN 2021 Annual Meeting.
Migraine and headache are common ailments of people living in the modern era. Dr Jon Marshall of The Singapore Headache and Migraine Clinic shares his insights with Pearl Toh on how to manage migraine and headache using non-pharmaceutical strategies, with a focus on the manual medicine approach.
Among atrial fibrillation (AF) patients with clinically defined heart failure, catheter ablation yields greater survival gains, freedom from AF recurrence, and quality of life boost than does drug therapy, according to the results of the CABANA AF* substudy.
Combination treatment with three or more antihypertensive drugs provides greater blood pressure (BP)-lowering effect than monotherapy, results of a study have shown. However, the net benefit may be lessened when side effects are considered.